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Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer related death in developed countries 1, 2 . Five-year survival is approximately 6% and survival beyond 12 months is unusual. Only 20% of patients are deemed suitable for attempted curative resection. Chemotherapy confers marginal benefit while the benefit of radiotherapy is debated 3 . Despite aggressive research, little improvement in patient survival has occurred in the last decade. In fact, the best chemotherapeutic treatments currently only prolong life by ~6-12 weeks 4 . The poor clinical outcome is attributed, at least in part, to the dense stromal reaction that arises during PDAC development and progression. In support of this notion, it has been shown that sequestration of chemotherapeutic agents such as gemcitabine can occur within the tumor stroma, effectively reducing the amount of the drug that can reach cancer cells 5 One of the major players in the stromal compartment of PDAC are pancreatic stellate cells (PSCs). Pancreatic stellate cells are resident cells of the pancreas and are predominantly periacinar in location and comprise 4-7% of total pancreatic parenchymal cells. In healthy pancreas, PSCs remain in a quiescent state 6 . PSCs are thought to play a primary role in maintenance of normal pancreatic architecture due to their ability to produce extra-cellular matrix (ECM) proteins as well as the enzymes that regulate ECM protein levels, such as matrix metallo-proteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). During an acute episode of pancreatic injury, PSCs are activated and express α-smooth muscle actin (α-SMA), proliferate, migrate, and secrete excess ECM proteins that lay down a lattice for regenerating epithelial cells. As the injury resolves, activated PSCs are lost through apoptosis 7 . MMPs secreted by the remaining PSCs degrade the excess fibrosis resulting in restitution of normal pancreatic tissue. However, during PDAC, an imbalance between ECM production and degradation results in an extensive and dense desmoplastic/fibrotic stroma produced by activated PSCs in which cancer cells are embedded 8 . Recent studies have alluded to PSCs playing an important role in promoting local growth of PDAC, facilitating regional and distant spread of PDAC cells 9, 10 , aiding PDAC immune-evasion [11] [12] [13] , and facilitating a stem cell niche in PDAC, all of which have a major impact on the progression of PDAC and play a role in its high recurrence rate. This has meant that the interactions between PDAC cells and PSCs have become increasingly studied. However, there are currently very limited in-vitro options to study these complex M A N U S C R I P T
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While the importance of these studies is not to be understated, increasing evidence in the literature shows the merits of utilizing 3D in vitro models rather than 2D, to replicate more precisely the biophysics of the tumor and surrounding micro-environment [14] [15] [16] .
Three-dimensional tumor spheroids have been grown by numerous groups which enable more accurate representation of tumor cell behaviors in a more complex 3D setting, which rely on cell-cell interactions, pathogenesis, transport of nutrients and therapeutics, and other important factors. However, current spheroid models do not provide a good model . However, the stroma compartment in these tumors is from an animal origin and these models are resourceintensive and time-consuming to create. Moreover, in vivo studies often provide only single end point measurements because visualizing the progress of the tumor and its response to therapies over multiple time points is difficult. These difficulties arise because of the inaccessibility of orthotopic tumors for microscopic methods or the animals needing to be sacrificed for histology analysis. Additionally, significant heterogeneity is seen in stromal reaction development in vivo 18 . These reasons lead to difficulty in obtaining mechanistic and time resolved data when studying tumor-stromal reactions in PDAC. It is, therefore, essential that more complex in-vitro cellular models that better mimic physiologic conditions within the tumor microenvironment be developed to study PDAC cell-stromal interactions for accurate predictions of drug or radiotherapy efficacy.
The importance of PDAC stroma interactions has been previously realized with the development of models incorporating the co-culture of PDAC and PSCs for a more 'organtypic' approach. For instance the use of 2D monolayer co-cultures 19 and models which incorporate PDAC and PSCs embedded in type I glycosaminoglycan scaffolds and in collagen type I or Matrigel 20 have been developed. We believe that this is specifically the first in-vitro model, which uses PSCs co-cultured with PDAC cells whilst employing a simple method to obtain a collagen rich spheroid model without adding any external extracellular matrix components. The PDAC-SS are highly reproducible with excellent uniformity, which M A N U S C R I P T
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5 uses a viscosity-inducing agent, methylcellulose for co-culturing both PDAC cell lines 21 and
PSCs in various ratios for active stroma production. We believe our PDAC-SS model provides an in-vitro model for PDAC stroma rich tumors and will further improve understanding of the interaction of PDAC cells and stromal constituents and the initiation and progression of the stroma commonly found in PDAC.
Materials and Methods

1. Materials
To prepare media for 3D PDAC-SS formation, cell media specific to the particular cell line (as described below) was supplemented with 20% methylcellulose stock solution.
For preparation of methylcellulose stock solution 6 g of autoclaved methylcellulose powder (M0512, Sigma-Aldrich) were dissolved in preheated 250 mL basal medium (60°C) for 20 min. Thereafter, 250 mL of medium (room temperature) containing double the amount of FBS for the particular cell line was added to a final volume of 500 mL and the whole solution was mixed overnight at 4°C. The final stock solution was aliquoted and cleared by centrifugation (5000 rpm for 2h at room temperature). Only the clear, highly viscous supernatant was used for the spheroid formation, which was approximately 90-95% of the stock solution. Human pancreatic stellate cells (PSCs) were isolated and prepared as previously described hTERT (pHIV7-CNPO-hTERT) as previously described in details. 23 PSCs carrying the hTERT or SV40-T were selected in 1 to 3 mg/mL G418 for 3 weeks (Invitrogen). Cells were maintained in DMEM with 10% FBS at 37°C in a humidified atmosphere of 5% CO 2 . 
Cell lines
A modified and improved hanging drop method for 3D PDAC-SS formation
Spheroids were created using a novel approach that we have previously described 21 .
Briefly, the approach combined two traditionally used techniques: the hanging-drop M A N U S C R I P T A C C E P T E D 
Generation of orthotopic PDAC tumors in mice
Animal studies were performed in accordance with the guidelines of the Animal 
Immunohistochemical evaluation
PDAC-SS were fixed in formalin, embedded in histogel TM (Thermo Scientific Richard-Allan Scientific, USA), processed in paraffin blocks and sectioned using standard techniques. PDAC-SS slides were stained with H&E, Ki67 (proliferation, mouse anti human Quantities of immature and mature collagen in PDAC-SS were quantified using Picro Sirius stain. Picro Sirius stained histology slides were imaged using a Nikon Eclipse This generated a binary image where white pixels represent the red or collagenous areas within the frame. The number of white pixels was divided by the total number of pixels in the image to give the percentage of collagenous pixels within the area. This was repeated for 10 PDAC-SS per group and for 20 frames of Capan-1 and PANC-1 tumors taken from 3 separate mice. The 20 frames were imaged from random areas of each tumor. Regions of both sparse and dense collagen were considered in all groups.
Scanning electron microscopy (SEM)
PDAC-SS were fixed by washing thrice with 0.1M sodium cacodylate buffer (CDB, Sigma, USA) followed by incubation in 2.5% glutaraldehyde (Sigma, USA) for 25 min at room temperature. Spheroids were washed thrice again in 0.1M CDB and subjected to an increasing concentration of ethanol (Thermo Fischer, USA) wash series for dehydration. The spheroids were then incubated in 1:1 t-butanol (Thermo Fischer, USA): ethanol mixture for 5 min and mounted on carbon tape upon an SEM stub. Immediately before imaging the samples were sputter coated with 50% platinum 50% palladium at a thickness of 5±0.2nm to ensure good electrical conductivity.
Light microscopy
Brightfield imaging for analysis of size distribution and shape of the micro-stroma and was captured at the desired time points using an Nikon Eclipse TE2000-U microscope fitted with a Nikon digital sight DS-Fi1 video camera.
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Reverse phase protein array (RPPA) assays were performed as described previously 29, 30 with minor modifications. Protein lysates were prepared from the cell culture samples 
Perfusion and drug efficacy analysis
For perfusion analysis, spheroids were exposed to 0.1μM FITC and fluorescence was tracked over time using a Nikon Eclipse TE2000-U microscope (Photometrics   TM   ) .For drug efficacy analysis, spheroids were exposed to 100uM of gemcitabine for 24h, then fixed with 4% PFA for 1h. Spheroids were then stained with Ki67 and ClPARP for histological analysis.
Liquid Circularity is defined as:
A value of 1.0 indicates a perfect circle. As the value approaches 0.0, it indicates an increasingly elongated polygon.
Solidity is defined as:
Ki67 expression before and after 24h of gemcitabine exposure was quantified from histological color images captured using a Nikon Eclipse TE2000-U microscope fitted with a CoolSNAP HQ 2 color camera (Photometrics TM ). ImageJ software (National Institute of Health, USA) was used to perform an intensity per unit area measure to quantify the amount of Ki67 present within the spheroids, since Ki67 positive nuclei stain dark brown and negative remain light blue.
Results
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We 
Proteomic analysis
We utilized the reverse-phase protein assay (RPPA) to identify differentially expressed biomarker proteins when PSCs are co-cultured with PANC-1 or PANC-1 cells are M A N U S C R I P T Brightfield microscopy revealed that PDAC-SS were smaller in diameter than their M A N U S C R I P T
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14 was used to identify significantly differentiated levels of total or phosphoproteins with pvalue < 0.05 and fold-change > 1.25 (or < 1/1.25). In comparison to single medias (PSCs or PANC-1), PSCs co-cultured in PANC-1 resulted in 66 up regulated and 43 down-
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this phenomenon is that PSCs and their production of ECM proteins, including collagen, create a tightly bound matrix on which the cancer cells grow. Furthermore, collagenous material may fill gaps between the cells to increase density of the overall tumor structure ( Figure 3D ). The increased density has major implications for the diffusion of drug molecules, and hence may be an important factor in PDAC drug resistance that is commonly observed in human patients. 
Quantification of collagen content in 3D PDAC-SS
One of the most widely used methods to visualize fibrosis in histological tissue is by staining it with Picro Sirius red [36] [37] [38] [39] [40] . Picro Sirius red, in contrast to more traditional stains like van Gieson and trichrome, has greater selectivity and thus is superior for both staining and quantification of collagen 40, 41 . Picro Sirius red stains collagenous positive regions within the spheroid red with non-collagenous regions counterstained blue. Figure 5 (and Figure S1) shows Percentage area fraction of collagen rich was quantified in capan-1 and PANC-1 spheroids due to them being the two most collagenous spheroid models. Limited increases in AsPc-1 M A N U S C R I P T
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2) yielded a 9% and 8% collagen content respectively. PANC-1 and Capan-1 in vivo tumors contained 37% and 24% collagen content respectively. This means the spheroids contained more than 4 times less collagen and 3 times less collagen than the in vivo tumors. However, PDAC-SS micro-tumors contained 25% (PANC-1) and 18% (Capan-1) collagenous material and hence more accurately represent the amount of collagen found in in vivo tumor tissues.
Human grade 3 stage 1 and 2 displayed both sparse and dense collagen regions (24% and 18%, respectively) and human grade 1 stage 3 possessed a large amount of sparse and dense collagen (70%). 
The effect of collagen in PDAC-SS on drug diffusion
Immunohistochemistry determined that the stromal regions in the PDAC-SS model consist M A N U S C R I P T
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capable of dissipating significant deformation energy 42 . In PDAC, collagen decreases tissue elasticity and increases interstitial pressure, resulting in reduced drug perfusion (Figure 7 ). 
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23 from spheroid border through to spheroid centre (lower inlaid images display typical position of intensity measurement across centre of spheroid) D) LC-MS quantification of gemcitabine content normalized to spheroid surface area (spheroid assumed to be perfectly spherical during normalization) in PANC-1 spheroids with and without PSCs (Scale bars = 300μm, * indicates p<0.05).
FITC fluorescent marker was used to measure the molecular perfusion (FITC MW 389g/mol, gemcitabine MW=263g/mol) through PDAC spheroids with and without PSCs ( Figure 6A-C) . LC-MS/MS was also performed to measure the relative gemcitabine content when spheroids with and without PSCs were incubated with 1000uM gemcitabine for 3h.
This physiological chemoresistance has previously been shown to be a major contributor to the reduced efficacy of chemotherapeutics in PDAC 43 . As shown in Figure 7 , diffusion of both FITC and gemcitabine was significantly impaired in stroma rich spheroids as compared with spheroids composed of only PDAC cells. Figure 8 shows that PDAC-SS model are Figure S7 ). *p<0.05. PANC1 spheroids with PSCs display a much more dense appearance and increased structural integrity after gemcitabine exposure as given by circularity and solidity measurements. Circularity and Solidity are given by equations 1 and 2 respectively and are shape descriptors used to quantify the structure of the spheroids before after gemcitabine exposure ( Figure 8 ). However, it was also observed that PANC1 spheroids with PSCs displays comparable ki67 content when compared to PANC-1 spheroids without PSCs before and after 120h of gemcitabine exposure ( Figure 9 ).
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A key histopathological feature of PDAC that is associated with its innate clinical and biological aggressiveness is its pronounced desmoplastic (stromal) reaction, which is now considered a potential therapeutic target in PDAC 44 . Stroma production is stimulated by cancer-cell derived growth factors including transforming growth factor-β (TGF β ), hepatocyte growth factor (HGF), fibroblast growth factor (FGF), insulin-like growth factor 1 (IGF-1) and epidermal growth factor (EGF) 45 .The desmoplastic reaction is composed of ECM proteins, primarily type I and III collagen, fibronectin and proteoglycans; small endothelium lined vessels; and a diverse population of cells including inflammatory cells, fibroblasts and stellate cells 46 . The stroma can form up to 90% of the tumor volume, a property which is unique to pancreatic cancer 47, 48 . The response of pancreatic cancer cells to chemotherapeutic agents in vitro is similar to cell lines derived from other solid tumors 48 .
However, pancreatic cancer patients have a limited response to drugs such as paclitaxel compared to breast and prostate cancer patients, suggesting that the unique tumor microenvironment in pancreatic cancer plays a role in chemoresistance 48 . Erkan et al 49 observed through staining pancreatic cancer tissue sections of patients for alpha smooth muscle actin (α-SMA the cytoskeletal protein marker for PSC activation) and collagen that a high activated stroma index (α-SMA/collagen) correlated with a poor prognosis.
Furthermore, the extensive ECM deposition by PSCs in pancreatic cancer causes distortion and compression of tumor vasculature by fibrous tissue, which contributes to tumor hypoxia, a determinant of chemoresistance 5, 50 . Therefore, improved in vitro models of PDAC with active stroma, such as our PDAC-SS model, will enhance understanding of the dynamic interaction between cancer cells and stroma compartments. This is an important consideration when designing new, effective therapeutic strategies for pancreatic cancer.
Both PDAC-SS and orthotopic tumors displayed both sparse and dense collagenous areas, indicated by the dim and bright red picro sirius positive regions, respectively. PANC-1 PDAC-SS contained very dense collagen whereas Capan-1 PDAC-SS contained collagen fibers that had shrunk, most probably through histology preparation, to leave blank spaces within the tumor architecture. This feature is also seen in orthotopic tumor collagen. Tumor spheroids grown without PSCs, in contrast, displayed only sparse collagen and notably no dense collagenous areas.
Although the main focus of this work considered stroma content, M A N U S C R I P T
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27 the viability of the spheroids at time points passed 2 weeks. However, the time point at harvest was chosen particularly because it represents the time in which the spheroids are most structurally viable. Since stroma rich pancreatic tumors should grow for longer periods of times in vivo (~1-2 months) we will not be able to maintain our spheroids for that long due to obvious limitations of the in vitro cell culture. However, at 7-10 day growth time we Proteomic-based approaches were also used to highlight potential genes, some of which are already known to be associated with PDAC-stroma interactions and fibrosis development in PDAC and some of which are not currently known. With a recent interest in moving toward an integrative, rather than reductionist, approach to PDAC biology in the post-genomic era, proteomic pattern comparisons between 2D and 3D mono and cocultures may lead to the discovery of numerous potential biomarkers that could be translated into diagnosis or prognosis in the clinical field.
Finally, we demonstrated that the PDAC-SS model displayed a lower molecular perfusion and a slight trend in higher proliferative index after 24h exposure of FITC M A N U S C R I P T
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gemcitabine. In in-vivo scenarios, 30-60mg/kg may be injected into the mouse with a fraction of this dose arriving at the tumor. This model can act as a bridge between in vitro and in vivo as in vitro doses are used however not all cells posses a cell-drug interface which is comparable to in vivo situation.
Conclusions
It is clear that the prominent stromal/desmoplastic reaction of PDAC can no longer be dismissed as a mere epiphenomenon of carcinogenesis. Indeed, available evidence strongly indicates that this stromal reaction, and in particular the cells responsible for its production, PSCs, likely play a key role at the different stages of pancreatic cancer development and response to therapy. Therefore, all components of this reaction ( 
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The MATLAB algorithm created to segment and count the number of red pixels within an image % %cd('C:\Users/matthewware/Desktop/');% specifies the directory or folder the image is located 
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